JMIR Mental Health
Internet interventions, technologies and digital innovations for mental health and behavior change
JMIR Mental Health focusses on digital health and Internet interventions, technologies and electronic innovations (software and hardware) for mental health, addictions, online counselling and behaviour change. This includes formative evaluation and system descriptions, theoretical papers, review papers, viewpoint/vision papers, and rigorous evaluations.
JMIR Mental Health publishes even faster and has a broader scope with including papers which are more technical or more formative/developmental than what would be published in the Journal of Medical Internet Research.
JMIR Mental Health features a rapid and thorough peer-review process, professional copyediting, professional production of PDF, XHTML, and XML proofs. The journal is indexed in PubMed, PubMed Central, and ESCI (Emerging Sources Citation Index).
JMIR Mental Health adheres to the same quality standards as JMIR and all articles published here are also cross-listed in the Table of Contents of JMIR, the worlds' leading medical journal in health sciences / health services research and health informatics.
Editorial Board members are currently being recruited, please contact us if you are interested (jmir.editorial.office at gmail.com).
Nov 14, 2017
Nov 8, 2017
Nov 1, 2017
Oct 31, 2017
Oct 30, 2017
Oct 24, 2017
Oct 23, 2017
Oct 20, 2017
Oct 19, 2017
Oct 18, 2017
Oct 17, 2017
Oct 16, 2017
Citing this Article
Right click to copy or hit: ctrl+c (cmd+c on mac)
Latest Submissions Open for Peer-Review:View All Open Peer Review Articles
Date Submitted: Nov 14, 2017
Open Peer Review Period: Nov 15, 2017 - Jan 10, 2018
This manuscript needs more reviewersPeer-Review Me
This article focuses on the ethical challenges presented by digital psychotherapy services that are direct-to-consumer and do not involve oversight by a professional mental health provider. These serv...
This article focuses on the ethical challenges presented by digital psychotherapy services that are direct-to-consumer and do not involve oversight by a professional mental health provider. These services include apps that connect users to peer counseling and counseling steered by artificial intelligence and conversational agents. These services can potentially assist in improving access to mental health care for the many people would otherwise not have the resources or ability to connect with a therapist. However, the lack of adequate regulation in this area exacerbates concerns over how safety, privacy, liability, and other ethical obligations to protect a client are addressed by these services. In the traditional therapeutic relationship, there are ethical obligations that serve to protect the interests of the client and provide warnings. In contrast, in a direct-to-consumer therapy app, there are not clear lines of accountability or associated ethical obligations to protect the user seeking mental health services. There is a need for increased oversight of direct-to-consumer non-professional psychotherapy services to better protect the consumer.
Development and feasibility testing of internet-delivered Acceptance and Commitment Therapy (iACT) for severe health anxiety
Date Submitted: Nov 5, 2017
Open Peer Review Period: Nov 7, 2017 - Jan 2, 2018
Background: Severe health anxiety (hypochondriasis), or illness anxiety disorder according to the DSM-5, is characterised by preoccupation with fear of suffering from a serious illness in spite of med...
Background: Severe health anxiety (hypochondriasis), or illness anxiety disorder according to the DSM-5, is characterised by preoccupation with fear of suffering from a serious illness in spite of medical reassurance. It is a debilitating, prevalent disorder associated with increased health care utilisation. Still, there is a lack of easily accessible specialised treatment for severe health anxiety. Objective: The present paper has two objectives; 1) to describe the development and setup of a new internet-delivered Acceptance and Commitment Therapy (iACT) programme for patients with severe health anxiety using self-referral and a video-based assessment, and 2) to examine the feasibility and potential clinical efficacy of iACT for severe health anxiety. Methods: Fifteen self-referred patients with severe health anxiety were diagnostically assessed by a video-based interview. They received 7 sessions of clinician-supported iACT comprising self-help texts, video clips, audio files and worksheets over 12 weeks. Self-report questionnaires were obtained at baseline, post-treatment and at 3-month follow-up (3MFU). The primary outcome was Whiteley-7 index measuring health anxiety severity. Depressive symptoms, health-related quality of life (HRQoL), life satisfaction and psychological flexibility were also assessed. A within-group design was employed. Means, standard deviations (SD) and effect sizes using the Standardized Response Mean were estimated. Post-treatment interviews were conducted to evaluate the patient experience of the usability and acceptability of the treatment setup and programme. Results: Self-referral and video-based assessment were well received. Most patients 12/15 (80%) completed the treatment, and only one patient dropped out. Post-treatment data were available for almost all patients 14/15 (93%) and 3MFU data for 12/15 (80%). Paired t-tests showed significant improvements on all outcome measures both at post-treatment and 3MFU except on one physical component subscale of HRQoL. Health anxiety symptoms decreased with 33.9 points at 3MFU (95% CI 13.6 to 54.3, t(11) = 3.66, P=0.004) with a large within-group effect size measured by the standardised response mean (SRM=1.06). Conclusions: Treatment adherence and potential efficacy suggest that iACT may be a feasible treatment for health anxiety. The uncontrolled design and small sample size limit the robustness of the findings. Therefore, the findings should be replicated in a randomised controlled trial. Potentially, iACT may increase availability and accessibility of specialised treatment for health anxiety. Clinical Trial: The study was approved by the Danish Data Protection Agency, Central Denmark Region (ID no. 1-16-02-427-14). URL: https://www.datatilsynet.dk/forside/
Digital access in working age and older adults and their carers attending psychiatry outpatient clinics
Date Submitted: Oct 6, 2017
Open Peer Review Period: Oct 8, 2017 - Dec 3, 2017
Background: Background: It has been suggested that improving access to mental health services, supporting self-management and increasing clinical productivity can be achieved through the delivery of...
Background: Background: It has been suggested that improving access to mental health services, supporting self-management and increasing clinical productivity can be achieved through the delivery of technology-enabled care via personal mobile and internet-based services, but there is little evidence available about whether working age and older adults with mental health problems or their carers have access to these technologies, or their confidence with these technologies. Objective: To ascertain the prevalence and range of devices used to access the internet in patients and carers attending general and older adult psychiatry outpatient services, and their confidence in using these technologies. Methods: We conducted an anonymous survey of 77 patients and carers from a general psychiatry and old age psychiatry clinic to determine rates of internet access and device ownership, and attitudes to technology enabled care. Results: We found high levels of internet access and confidence in using the internet in working age adults, their carers, and older adult carers but not in older adult patients. Smartphone usage predominated in working age adults and their carers. Older adult carers were more likely to use desktop or laptop computers. In our sample, tablets were the least popular form factor. Conclusions: Access rates and uptake of internet based services have the potential to be high in working age adults and their carers, but are likely to be significantly lower among older adult patients attending psychiatry clinics. Applications designed for tablets are likely to have low uptake. All groups identified appointment reminders as likely to be beneficial.
Date Submitted: Sep 23, 2017
Open Peer Review Period: Sep 24, 2017 - Nov 19, 2017
Lamotrigine is an anticonvulsant used for the treatment of bipolar disorder, especially for depressive episodes. A randomized placebo controlled trial was conducted and self-reported mood scores were...
Lamotrigine is an anticonvulsant used for the treatment of bipolar disorder, especially for depressive episodes. A randomized placebo controlled trial was conducted and self-reported mood scores were collected over a period of 52 weeks. Different features were computed from the weekly time series produced by each subject. The coefficient of variation (σ/μ) and detrended fluctuation analysis scaling exponent (α), a measure of scaling and long-range persistence (long memory) in time series, were selected as having the most explanatory power. Data from patients taking lamotrigine show a general decrease in depression score in comparison to the patients taking placebo. The time series of lamotrigine patients tend to be rougher than the placebo group. A classifier was built and, based on the two chosen metrics, we are able to achieve a classification accuracy of more than 60% in predicting the treatment mode.